Net Cash Provided by (Used in) Operating Activities |
-22.9K |
USD |
-134% |
Q1 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
22.5K |
USD |
+193% |
Q1 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
75M |
shares |
0% |
Q2 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
2.87M |
shares |
0% |
Q2 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-17 |
USD |
+99.2% |
Q1 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
63 |
USD |
-92.3% |
Q2 2024 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
527K |
USD |
+3338% |
Q4 2023 |
FY 2024 |
Deferred Tax Assets, Gross |
527K |
USD |
+3338% |
Q4 2023 |
FY 2024 |
Depreciation |
143 |
USD |
-95.3% |
Q1 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-19.6K |
USD |
+41% |
Q2 2024 |
Q2 2025 |
Property, Plant and Equipment, Gross |
88K |
USD |
|
Q2 2023 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
250K |
USD |
+255% |
Q4 2023 |
FY 2024 |
Additional Paid in Capital |
35.8K |
USD |
0% |
Q2 2024 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2024 |
Interest Expense |
1.36K |
USD |
|
Q2 2024 |
Q2 2025 |